select a format

Single User License
USD 125 INR 0
Site License
USD 250 INR 0
Corporate User License
USD 375 INR 0

Alternatively

Request a quote
Request a Customized research
Request for Sample Report

NEWSLETTER BY CATEGORY




Recent Viewed Reports


Why Ken Reasearch?


Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"


Neos Therapeutics Inc (NEOS)-Financial and Strategic SWOT Analysis Review

Neos Therapeutics Inc (NEOS)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH187693FSA
  • |
  • Pages: 43
  • |
  • July 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Neos Therapeutics Inc (NEOS)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Neos Therapeutics Inc (Neos Therapeutics), formerly Neostx Inc, develops, manufactures, and commercializes branded products. The company's portfolio includes Adzenys XR-ODT that is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in patients of six years age and older; and Tussionex that is indicated for cough and upper respiratory symptoms of cold. Its pipeline encompasses investigational candidates targeted at the treatment of ADHD. Neos Therapeutics' products are orally disintegrating tablets (ODT) or liquid suspension dosage forms based on its proprietary extended-release (XR) drug delivery technology platform. The company also manufactures and markets its generic equivalent of the branded product Tussionex. Neos Therapeutics is headquartered in Grand Prairi, Texas, the US.

Neos Therapeutics Inc Key Recent Developments

May 09,2017: Neos Therapeutics Reports First Quarter 2017 Financial Results

Mar 14,2017: Neos Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results

Nov 10,2016: Neos Therapeutics Reports Third Quarter 2016 Financial Results

Aug 11,2016: Neos Therapeutics Announces Second Quarter 2016 Financial Results

May 31,2016: Neos Therapeutics Appoints Juergen Martens as Chief Technology and Operations Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Neos Therapeutics Inc-Key Facts 5

Neos Therapeutics Inc-Key Employees 6

Neos Therapeutics Inc-Key Employee Biographies 7

Neos Therapeutics Inc-Major Products and Services 8

Neos Therapeutics Inc-History 9

Neos Therapeutics Inc-Company Statement 10

Neos Therapeutics Inc-Locations And Subsidiaries 12

Head Office 12

Section 2-Company Analysis 13

Neos Therapeutics Inc-Business Description 13

Neos Therapeutics Inc-Corporate Strategy 14

Neos Therapeutics Inc-SWOT Analysis 15

SWOT Analysis-Overview 15

Neos Therapeutics Inc-Strengths 15

Neos Therapeutics Inc-Weaknesses 16

Neos Therapeutics Inc-Opportunities 17

Neos Therapeutics Inc-Threats 18

Neos Therapeutics Inc-Key Competitors 19

Section 3-Company Financial Ratios 20

Financial Ratios-Capital Market Ratios 20

Financial Ratios-Annual Ratios 21

Performance Chart 23

Financial Performance 23

Financial Ratios-Interim Ratios 24

Financial Ratios-Ratio Charts 25

Section 4-Company's Lifesciences Financial Deals and Alliances 26

Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26

Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27

Neos Therapeutics Inc, Recent Deals Summary 28

Section 5-Company's Recent Developments 29

May 09, 2017: Neos Therapeutics Reports First Quarter 2017 Financial Results 29

Mar 14, 2017: Neos Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results 30

Nov 10, 2016: Neos Therapeutics Reports Third Quarter 2016 Financial Results 32

Aug 11, 2016: Neos Therapeutics Announces Second Quarter 2016 Financial Results 33

May 31, 2016: Neos Therapeutics Appoints Juergen Martens as Chief Technology and Operations Officer 34

May 16, 2016: Neos Therapeutics Announces First Quarter 2016 Financial Results 35

May 16, 2016: Neos Therapeutics Announces Closing of $60 Million Term Debt Financing and First Quarter 2016 Financial Results 36

Mar 17, 2016: Neos Therapeutics Announces Fourth Quarter and Full Year 2015 Financial Results 37

Section 6-Appendix 39

Methodology 39

Ratio Definitions 39

About GlobalData 43

Contact Us 43

Disclaimer 43

List of Figures

Neos Therapeutics Inc, Performance Chart (2013-2016) 23

Neos Therapeutics Inc, Ratio Charts 25

Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26

Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 27

List of Tables

Neos Therapeutics Inc, Key Facts 5

Neos Therapeutics Inc, Key Employees 6

Neos Therapeutics Inc, Key Employee Biographies 7

Neos Therapeutics Inc, Major Products and Services 8

Neos Therapeutics Inc, History 9

Neos Therapeutics Inc, Key Competitors 19

Neos Therapeutics Inc, Ratios based on current share price 20

Neos Therapeutics Inc, Annual Ratios 21

Neos Therapeutics Inc, Annual Ratios (Cont...1) 22

Neos Therapeutics Inc, Interim Ratios 24

Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26

Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27

Neos Therapeutics Inc, Recent Deals Summary 28

Currency Codes 39

Capital Market Ratios 39

Equity Ratios 40

Profitability Ratios 40

Cost Ratios 41

Liquidity Ratios 41

Leverage Ratios 42

Efficiency Ratios 42

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Neos Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com